Explore News By Topic

05/26/2017

FDA approves first precision medicine for the treatment of cancers with certain genetic defects, including prostate cancer

On May 23, 2017, the field of precision medicine achieved a major milestone with the FDA’s first ever approval of a cancer therapy based entirely on a tumor’s unique characteristics and not where the tumor developed in the body.  In other words, while therapies to date have been approved for... Read More